FDA Inspection 1066603 — Berlimed, S.A.

Berlimed, S.A. — FEI 3004492234

The FDA completed an inspection of Berlimed, S.A. on September 25, 2018 in Alcala de Henares. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 25, 2018
Fiscal Year
2018
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Alcala de Henares (Spain)

Citations

IDCFRDescription
430321 CFR 211.67(b)Written procedures fail to include